A61K 31/453
Containing a six-membered ring with oxygen as a ring hetero atom
Official title: containing a six-membered ring with oxygen as a ring hetero atom
A61K31/453 (Containing a six-membered ring with oxygen as a ring hetero atom) appears on 289 US grants and 518 published applications in this corpus.
Search patents in A61K- Granted patents
- 289
- Published applications
- 518
- Assignees
- 273
- Inventors
- 1,311
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 8 | 0 |
| 1996 | 3 | 0 |
| 1997 | 5 | 0 |
| 1998 | 10 | 0 |
| 1999 | 5 | 0 |
| 2000 | 7 | 0 |
| 2001 | 2 | 8 |
| 2002 | 8 | 16 |
| 2003 | 6 | 16 |
| 2004 | 7 | 13 |
| 2005 | 5 | 14 |
| 2006 | 4 | 17 |
| 2007 | 1 | 9 |
| 2008 | 2 | 10 |
| 2009 | 3 | 14 |
| 2010 | 4 | 15 |
| 2011 | 5 | 17 |
| 2012 | 2 | 23 |
| 2013 | 16 | 22 |
| 2014 | 9 | 17 |
| 2015 | 23 | 25 |
| 2016 | 12 | 20 |
| 2017 | 17 | 20 |
| 2018 | 15 | 25 |
| 2019 | 18 | 27 |
| 2020 | 21 | 29 |
| 2021 | 15 | 27 |
| 2022 | 15 | 31 |
| 2023 | 10 | 26 |
| 2024 | 9 | 25 |
| 2025 | 8 | 31 |
| 2026 | 13 | 21 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- TEAD inhibitors29 Sep 2026US 12,747,207 B2Orion Corporation
- Small molecule inhibitors of mammalian SLC6A19 function11 Aug 2026US 12,703,692 B2Jnana Therapeutics Inc.
- Pharmaceutical use of ketoamide-based compound26 May 2026US 12,636,275 B2Shanghai Institute of Materia Medica, Chinese Academy of Sciences
- Method of diagnosing overactive bladder disorder26 May 2026US 12,638,459 B2University of Portsmouth Higher Education Corporation
- 3-phenylpropylamine derivative21 Apr 2026US 12,606,533 B2Daiichi Sankyo Company, Limited
- Compounds for positive modulation of the autophagy-lysosomal pathway and methods of use27 Aug 2026US 2026/0250256 A1
- Antimalarial endoperoxide derivatives for the treatment of myelodyplastic syndrome20 Aug 2026US 2026/0242391 A1The Scripps Research Institute
- Anti-her2 antibody-drug conjugate for treating breast cancer13 Aug 2026US 2026/0232833 A1Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- Thiochroman derivative and preparation method therefor and use thereof6 Aug 2026US 2026/0226035 A1Shanghai Institute of Materia Medica, Chinese Academy of Sciences
- Treatment of hematological malignancies with inhibitors of menin30 Jul 2026US 2026/0216190 A1Kura Oncology, Inc.
Most cited
By later US patents
- Anti-estrogenic compounds and compositions119US 5,395,842 AEndorecherche, Inc. · 1995
- Methods for inhibiting bone loss117US 5,393,763 AEli Lilly and Company · 1995
- Method for improving pharmacokinetics107US 6,037,157 AAbbott Laboratories · 2000
- Inhibitors of rotamase enzyme activity76US 5,798,355 AGPI NIL Holdings, Inc. · 1998
- Methods for the treatment and prevention of ileus73US 6,469,030 B2Adolor Corporation · 2002